在化学合成方面最重要的能力是商业化的能力，公司在产品商 业化方面是具有竞争力的。新能源行业是"足够宽、足够长" 的赛道。另一方面，公司当时业务以海外客户的 CDMO 业务 为主，拓展新能源业务能有效对冲经营风险，保障公司发展稳 健。尽管在新领域开拓过程中不可避免会面临一些挑战，公司 目前正稳步推进相关规划，积极提升技术与运营能力，缩小与 行业领先者的差距。 3、公司英国基地今年情况如何？马来西亚基地建设情况如 何？这两个海外基地未来有何规划？ 公司英国基地 25 年整体生产经营情况平稳，26 年也将保 持稳健。马来西亚基地计划投资 2 亿美金并分期建设，目前仍 在第一期建设中，马来西亚基地目前规划以生产植保 CDMO 产 品为主，计划将于 26 年底完成第一期项目建设，并于 27 年根 据客户订单情况按步投产。未来，公司可以向客户提供的来自 中国、英国和马来西亚基于产品生命周期不同需求的全产业链 服务，利用中国完善的化工供应链配套设施及有竞争性的基础 资源，协同英国和马来西亚灵活的生产及登记政策，为客户、 为行业提供差异化的、一站式的供应链解决方案。 4、公司医药业务情况如何？新客户拓展及业务规划如何？ 联化 ...

以下文章来源于36氪 ，作者胡香赟 海若镜 36氪 . 36氪是服务中国新经济参与者的卓越品牌和开创性平台，提供新锐深度的商业报道，强调趋势和价值，我们的slogan是：让一部分人先看到未来。 已搭建从反应体系、催化剂，到反应器设计、 纯化工艺的系统性生产体系。 文 ｜ 胡香赟 编辑 ｜ 海若镜 编者荐语： 日经中文网与36氪开展内容交换合作。将精选36氪的精彩独家财经、科技、企业资讯，与读者分享。 "考虑到未来绿色可持续的工业生态，电化学技术可以通过对传统化工行业的电气化改造，在提供高附加值产品的同时，还能实现高效降碳排，具有巨大的 社会价值和经济价值。"金庆丰认为。 电化学合成， 从"实验室"到"产业化" 所谓电化学合成，核心是将电能直接转化为化学能，利用电子作为"试剂"来驱动有机化学反应。通过精确控制施加的电压来调节电子的"能量"，从而选择性 地氧化或还原分子中特定的官能团，实现高选择性的化学转化。 "相较传统化学合成而言，电化学合成成本更低、安全性更高，且能实现独特分子结构合成；与合成生物学相比，其效率与普适性更优，产业化放大难度更 低。"金庆丰介绍称。 | 特性 | 有机电化学合成 | 传统化学合成 ...

文｜胡香赟 此外，湖南大学化工学院书记、教授王双印任易合科技首席科学家，湖南大学教授邹雨芹任易合科技研发主管，皆深度参与公司催化剂研发和反应机理研 究。王双印是两期国家杰出青年基金获得者、科技部重点研发计划首席科学家。 "考虑到未来绿色可持续的工业生态，电化学技术可以通过对传统化工行业的电气化改造，在提供高附加值产品的同时，还能实现高效降碳排，具有巨大的 社会价值和经济价值。"金庆丰认为。 电化学合成，从"实验室"到"产业化" 所谓电化学合成，核心是将电能直接转化为化学能，利用电子作为"试剂"来驱动有机化学反应。通过精确控制施加的电压来调节电子的"能量"，从而选择性 地氧化或还原分子中特定的官能团，实现高选择性的化学转化。 "相较传统化学合成而言，电化学合成成本更低、安全性更高，且能实现独特分子结构合成；与合成生物学相比，其效率与普适性更优，产业化放大难度更 低。"金庆丰介绍称。 编辑｜海若镜 36氪独家获悉，易合科技已完成数千万元天使轮和天使+轮融资。天使轮投资方为险峰长青，天使+轮投资方为天使投资人费革胜，募集资金主要用于团队 组建、实验室工艺优化、及一期产品中试。 另据了解，近期，易合科技已开启新一轮融 ...

Group 1: Technological Innovation in Jiangxi - Jiangxi is actively constructing a work system led by enterprises, guided by the government, and supported by universities and research institutions to overcome technological bottlenecks [1] - The province has launched six major actions to promote technological innovation, optimizing the innovation platform system and integrating technological and industrial innovation [1] - According to the "China Regional Science and Technology Innovation Evaluation Report 2025," Jiangxi's comprehensive science and technology innovation index is 69.63%, ranking 15th nationally [1] Group 2: Aviation Industry Development - The eVTOL (electric vertical takeoff and landing) sector has become a popular area for innovation, with Jiangxi leveraging its strong general aviation manufacturing foundation to upgrade its aviation industry [2] - A cooperation agreement was signed in May 2024 to address bottlenecks in eVTOL development, focusing on key technologies such as aerodynamic design and high-performance electric propulsion systems [3] - The successful first flight of the AR-E3000 eVTOL prototype in July 2024 demonstrates Jiangxi's advancements in the field, with the aircraft designed for urban transportation and emergency rescue in complex terrains [4] Group 3: Pharmaceutical Industry Transformation - Jiangxi's Renhe Group has transitioned from traditional to intelligent pharmaceutical manufacturing, utilizing smart equipment for the production of traditional Chinese medicine [5] - The company has developed a new granule formulation of the ancient prescription "Er Dong Tang," achieving a significant milestone in modernizing traditional medicine [6] - The successful production approval of "Er Dong Tang" granules marks a key development in Jiangxi's pharmaceutical industry, providing a model for high-quality development [6] Group 4: Swine Breeding Innovation - Research at Jiangxi Agricultural University has focused on genetic differences affecting pig growth and meat quality, leading to the development of the "Zhongxin No.1" breeding chip [7] - This chip allows for the analysis of over 56,000 genetic loci across 96 samples, facilitating the breeding of pigs with desirable traits [7] - The introduction of the "Shanxia Changhei" breed represents a breakthrough in local pig breeding, with over 15,000 breeding pigs sold across 12 provinces [8] Group 5: Major Technological Projects - The "2030 Pioneer Project" aims to address significant technological innovation needs in Jiangxi, planning to implement around 100 major projects by 2030 [8] - As of now, 17 major projects have been initiated, with 37 projects underway, some achieving preliminary results that are being transformed into industrial productivity [8] Group 6: Health Food Innovation - A research team from Nanchang University has developed a series of polysaccharide-based health foods using local medicinal resources, creating a new green manufacturing industry [9][10] - The project has received national recognition, with significant economic benefits reported from the commercialization of these health products [10] Group 7: Continuous Flow Technology in Pharmaceuticals - A team from Jiangxi Normal University has developed a continuous flow process for chemical synthesis, improving production efficiency and safety compared to traditional batch methods [11] - This technology has been applied in the production of various pharmaceuticals and agrochemicals, with total contract amounts reaching 138 million yuan [11]

Core Viewpoint - The article discusses the revival of electrochemistry in synthetic chemistry, highlighting its potential in enzyme applications and the challenges faced in utilizing electrochemistry to unlock new catalytic modes for enzymes [2]. Group 1: Research Findings - A research team from Nanjing University published a paper in Nature on May 28, 2025, demonstrating a new catalytic function of ThDP-dependent enzymes through the integration of electrocatalysis and enzyme catalysis, achieving dynamic kinetic oxidation of aldehydes to chiral carboxylic acids [2]. - The study reported a robust electroenzymatic method for the efficient synthesis of ten (S)-arylpropionic acid anti-inflammatory drugs, such as ibuprofen and naproxen, with enantiomeric selectivity reaching 99% ee and enzyme loading as low as 0.05 mol% [4]. - Mechanistic studies revealed that the electroenzyme plays multiple roles in precise substrate recognition, accelerating racemization, and facilitating electron transfer events for kinetic matching [5]. Group 2: Recent Publications - The research team has published three papers in Nature over the past two years, including a study on December 18, 2023, that developed a dual catalytic system combining ThDP-dependent enzymes and photocatalysis, significantly expanding enzyme catalytic functions and providing new strategies for chiral precision control in chemical fields [7]. - Another publication on November 22, 2024, introduced a synergistic photobiocatalysis system for enantioselective triple radical sorting, overcoming the limitations of natural enzymes that typically catalyze only 1-2 substrates, thus empowering green biomanufacturing [10].

Core Viewpoint - The recent surge in mergers and acquisitions (M&A) in the A-share market reflects a deep-seated logic of industrial upgrading and strategic transformation, showcasing the diversification and specialization of the current M&A landscape [1] Group 1: Characteristics of Recent M&A Activity - Cash transactions dominate the current wave of M&A, with companies accelerating their entry into new sectors [2] - The M&A activities are driven by three strategic directions: seeking breakthroughs in technological innovation, enhancing risk resilience through resource integration, and capitalizing on policy incentives to enter emerging sectors like AI and semiconductors [2] Group 2: Industry Chain Integration - Industry chain integration is a core driver of M&A among A-share companies, with firms pursuing horizontal and vertical integration to enhance competitiveness [3] - Jiangsu Zongyi Co., Ltd. plans to acquire control of Jiangsu Jilai Microelectronics Co., Ltd. to extend its reach into the power semiconductor sector [3] - Suzhou Dongshan Precision Manufacturing Co., Ltd. intends to acquire 100% of Groupe Mécanique Découpage to optimize its debt structure and enhance its capabilities in the automotive parts sector [3][4] Group 3: Strategic Focus and Diversification - Companies are adopting divergent strategies, with some focusing on core businesses while others pursue diversification [5] - Jiangsu Zongyi's acquisition of Jilai Microelectronics aims to strengthen its position in the integrated circuit sector, enhancing its technical capabilities and market share [5] - China National Pharmaceutical Group plans to acquire Beijing Jinsui Technology to enter the e-commerce service sector, diversifying its business and revenue streams [5] Group 4: Investment Trends - Beijing Lier High-Temperature Materials Co., Ltd. is investing in Shanghai Zhenliang Intelligent Technology Co., Ltd. to enter the AI chip market, reflecting a commitment to both core business and new growth areas [6] Group 5: Valuation and Compliance Concerns - Valuation and compliance are critical issues in M&A transactions, directly impacting their success [8] - Huafeng Chemical Co., Ltd. terminated its planned acquisition of Zhejiang Huafeng Synthetic Resin Co., Ltd. due to high valuation and lack of shareholder approval, highlighting the risks associated with high-premium related transactions [8][9] - Companies are advised to establish a scientific valuation system and ensure transparency in operations to mitigate risks associated with related-party transactions [10]